Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys
<p>Abstract</p> <p>Background</p> <p>Arterial proteoglycans are implicated in the pathogenesis of atherosclerosis by their ability to trap plasma lipoproteins in the arterial wall and by their influence on cellular migration, adhesion and proliferation. In addition, dat...
Main Authors: | Litwak Kenneth N, Vogl-Willis Catherine A, Wagner Janice D, Edwards Iris J, Cefalu William T |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-04-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://www.cardiab.com/content/3/1/6 |
Similar Items
-
The heparan sulfate and its diverse biological activities
by: Kaznowska-Bystryk Iwona
Published: (2014-12-01) -
Heparan sulfate and cell division
by: Porcionatto M.A., et al.
Published: (1999-01-01) -
Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character
by: Ainara Crespo, et al.
Published: (2018-06-01) -
Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice
by: Victor Brito, et al.
Published: (2017-11-01) -
Can We Produce Heparin/Heparan Sulfate Biomimetics Using “Mother-Nature” as the Gold Standard?
by: Brooke L. Farrugia, et al.
Published: (2015-03-01)